Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cameron Lacey is active.

Publication


Featured researches published by Cameron Lacey.


Journal of Clinical Neuroscience | 2009

Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease

Shen-Yang Lim; Sean S. O'Sullivan; Katya Kotschet; David A. Gallagher; Cameron Lacey; Andrew David Lawrence; Andrew J. Lees; Dudley J. O'Sullivan; Richard F. Peppard; Julian P. Rodrigues; Anette Schrag; Paul Silberstein; Stephen Tisch; Andrew Evans

Data regarding the effect of deep brain stimulation (DBS) surgery on the dopamine dysregulation syndrome (DDS), impulse control disorders (ICDs) and punding in Parkinsons disease (PD) are limited. We present a case series of 21 operated PD patients who had exhibited DDS, ICDs or punding at some stage during the disease. DDS remained unimproved or worsened post-operatively in 12/17 patients with pre-operative DDS (71%) (nine bilateral subthalamic nucleus [STN], one right-sided STN, two bilateral globus pallidus internus [GPi] DBS). DDS improved or resolved after bilateral STN DBS in 5/17 patients with pre-operative DDS. DDS apparently developed for the first time after bilateral STN DBS in two patients, although only after a latency of eight years in one case. One patient without reported pre-operative DDS or ICDs developed pathological gambling post-STN DBS. One patient had pathological gambling which resolved pre-operatively, and did not recur post-DBS. Thus, DDS, ICDs and punding may persist, worsen or develop for the first time after DBS surgery, although a minority of patients improved dramatically. Predictive factors may include physician vigilance, motor outcome and patient compliance.


Epilepsia | 2009

Psychiatric comorbidity and impact on health service utilization in a community sample of patients with epilepsy

Cameron Lacey; Michael R. Salzberg; Helene Roberts; Tom Trauer; Wendyl D’Souza

We aimed to determine the level of psychological distress in community‐treated patients with epilepsy and to determine if this distress is associated with increased health service use. The Australian National prescription database was used to recruit patients with epilepsy onto the Tasmanian Epilepsy Register (TER). Psychological distress was measured using the K10 in the TER patients and compared to the Tasmanian population using the National Health Survey 2004–5. Of the 1,180 on the TER, 43 withdrew, 36 died, and 262 were excluded. Of 839 patients, 652 completed the K10 (78%). High–very high levels of psychological distress were observed in patients with epilepsy compared with the general population [odds ratio (OR) 2.14, 95% confidence interval (CI) 1.79–2.56]. Patients with high–very high psychological distress had increased attendance at general practitioners (p < 0.001), specialists (p = 0.02), and emergency departments (p = 0.004). Psychological distress is increased in community‐treated patients with epilepsy compared to the general population, and is associated with increased health service use.


Epilepsy & Behavior | 2007

The neurologist, psychogenic nonepileptic seizures, and borderline personality disorder

Cameron Lacey; Mark J. Cook; Michael R. Salzberg

Patients with psychogenic nonepileptic seizures (PNES) are common in tertiary epilepsy centers, emergency departments, and neurological practices. Psychiatric discussion of patients with PNES has emphasized the role of trauma and dissociation. Personality disorder has been considered, but its extensive implications for neurological management have not been fully appreciated. We propose that the most difficult aspects of management stem not from the convulsive episodes, but from the personality disorder that frequently accompanies them. Although it is not the neurologists role to treat personality disorder, the conduct of the physician-patient relationship can have potent consequences for good or ill on the outcome. We present a brief guide to current concepts of personality disorder; discuss the literature concerning its association with PNES, and offer practical guidelines for the conduct of the neurologist-patient relationship. This perspective offers resolutions to longstanding controversies, including how to communicate the diagnosis, discontinuing medication, and ongoing neurological contact.


Australasian Psychiatry | 2007

Hepatitis C in Psychiatry Inpatients: Testing Rates, Prevalence and Risk Behaviours

Cameron Lacey; Steve Ellen; Harriet Devlin; Edwina Wright; Anne Mijch

Objective: Estimates for the prevalence of hepatitis C among people with a serious mental illness are high compared with the general population. High-risk behaviours commonly associated with mental illness may contribute to the estimated increased prevalence. This study aims to assess the contribution of risk behaviours to blood-borne virus infection in psychiatric populations in Australia, and to determine whether a pre- and post-test education and counselling program increases the number of patients willing to be tested for hepatitis C. Method: The proportion of psychiatric inpatients being screened for hepatitis C at the Alfred Hospital over a 6-month period was obtained by retrospective review of the number of admissions and hepatitis C serology tests. The change in screening rate was prospectively recorded following the introduction of an education and voluntary screening program. In the study period, 346 people were approached and 84 (24%) agreed to participate. Pre- and post-test counselling, including a thorough risk assessment, were offered to all participants. Venous blood was tested for hepatitis C. A modified version of the Risk Behaviour Questionnaire was used to measure sexual and drug-related risk behaviour. Results: The proportion of inpatients being tested for hepatitis C increased from 9% in the 6 months prior to the study, to 18% during the study (p <0.01). The rate of hepatitis C in those consenting to testing was 19.4%. Participants reported high rates of risk-taking behaviours, including intravenous drug use and unprotected sex. Conclusions: An education and counselling program can increase rates of screening among psychiatric inpatients. There are high rates of risk-taking behaviour among this group of psychiatric inpatients, which may contribute to the higher prevalence of hepatitis C compared to the general population.


Australian and New Zealand Journal of Public Health | 2016

Comprehensive clinical assessment of home-based older persons within New Zealand: an epidemiological profile of a national cross-section.

Philip J. Schluter; Annabel Ahuriri-Driscoll; Tim J. Anderson; Paul Beere; Jennifer Brown; John C. Dalrymple-Alford; Tim David; Andrea Davidson; Deborah Gillon; John P. Hirdes; Sally Keeling; Simon Kingham; Cameron Lacey; Andrea Kutinova Menclova; Nigel Millar; Vince Mor; Hamish A. Jamieson

Objective: Since 2012, all community care recipients in New Zealand have undergone a standardised needs assessment using the Home Care International Residential Assessment Instrument (interRAI‐HC). This study describes the national interRAI‐HC population, assesses its data quality and evaluates its ability to be matched.


Australian and New Zealand Journal of Psychiatry | 2012

Effectiveness of interventions to improve medication adherence in bipolar disorder

Marie Crowe; Richard J. Porter; Maree Inder; Cameron Lacey; Dave Carlyle; Lynere Wilson

Objective: To identify interventions that improve medication adherence in bipolar disorder. Method: A review of the literature from 2004 to 2011 was conducted using Medline and manual searching. Results: Eleven studies were identified as meeting inclusion criteria. Five studies demonstrated improved medication adherence. No characteristics of the interventions, clinical characteristics of the groups or methodological factors distinguished those psychosocial interventions that demonstrated improvement from those that did not. Conclusions: While only a few interventions improved adherence, most improved clinical outcomes. Issues were also identified about the way in which adherence is defined. It is proposed that incorporating patient preferences into measures of adherence within the context of a disorder-specific psychosocial intervention may provide an approach that demonstrates both improved adherence and improved clinical outcomes. However this requires further research.


Epilepsy & Behavior | 2015

Risk factors for depression in community-treated epilepsy: systematic review.

Cameron Lacey; Michael R. Salzberg; Wendyl D'Souza

OBJECTIVE Depression is one of the most common psychiatric comorbidities in epilepsy; however, the factors contributing to this association remain unclear. There is a growing consensus that methodological limitations, particularly selection bias, affect many of the original studies. A systematic review focussed on community-based studies offers an alternative approach for the identification of the risk factors for depression. METHODS Searches were performed in MEDLINE (Ovid), 2000 to 31 December 2013, EMBASE, and Google Scholar to identify studies examining risk factors for depression in epilepsy. Community-based studies of adults with epilepsy that reported at least one risk factor for depression were included. RESULTS The search identified 17 studies that met selection criteria, representing a combined total of 12,212 people with epilepsy with a mean sample size of 718. The most consistent risk factors for depression were sociodemographic factors, despite the fact that most studies focus on epilepsy-related factors. SIGNIFICANCE Most studies lacked a systematic conceptual approach to investigating depression, and few risk factors were consistently well studied. Future community-based studies require a detailed systematic approach to improve the ability to detect risk factors for depression in epilepsy. Psychological factors were rarely studied in community-based samples with epilepsy, although the consistent association with depression in the few studies that did suggests this warrants further examination.


Depression and Anxiety | 2015

CHANGES IN NEUROPSYCHOLOGICAL FUNCTION AFTER TREATMENT WITH METACOGNITIVE THERAPY OR COGNITIVE BEHAVIOR THERAPY FOR DEPRESSION

Samantha J. Groves; Richard J. Porter; Jennifer Jordan; Robert G. Knight; Janet D. Carter; Virginia V.W. McIntosh; Kumari Fernando; Chris Frampton; Roger T. Mulder; Cameron Lacey; Peter R. Joyce

Metacognitive therapy (MCT) is an innovative treatment model addressing patterns of negative thinking seen in emotional disorders. Unlike cognitive behavior therapy (CBT), MCT has strategies targeting dysfunctional cognitive and metacognitive processes underlying perseverative thinking patterns and attentional biases. The aim of this pilot study was to compare changes in neuropsychological functioning related to executive function and attention in outpatients with depression following treatment with MCT or CBT.


Australian and New Zealand Journal of Psychiatry | 2014

Metacognitive therapy versus cognitive behavioural therapy for depression: a randomized pilot study.

Jennifer Jordan; Janet D. Carter; Virginia V.W. McIntosh; Kumari Fernando; Chris Frampton; Richard J. Porter; Roger T. Mulder; Cameron Lacey; Peter R. Joyce

Objective: Metacognitive therapy (MCT) is one of the newer developments within cognitive therapy. This randomized controlled pilot study compared independently applied MCT with cognitive behavioural therapy (CBT) in outpatients with depression to explore the relative speed and efficacy of MCT, ahead of a planned randomized controlled trial. Method: A total of 48 participants referred for outpatient therapy were randomized to up to 12 weeks of MCT or CBT. Key outcomes were reduction in depressive symptoms at week 4 and week 12, measured using the independent-clinician-rated Quick Inventory of Depressive Symptomatology16. Intention-to-treat and completer analyses as well as additional methods of reporting outcome of depression are presented. Results: Both therapies were effective in producing clinically significant change in depressive symptoms, with moderate-to-large effect sizes obtained. No differences were detected between therapies in overall outcome or early change on clinician-rated or self-reported measures. Post-hoc analyses suggest that MCT may have been adversely affected by greater comorbidity. Conclusions: In this large pilot study conducted independently of MCT’s developers, MCT was an effective treatment for outpatients with depression, with similar results overall to CBT. Insufficient power and imbalanced comorbidity limit conclusions regarding comparative efficacy so further studies of MCT and CBT are required.


Acta Psychiatrica Scandinavica | 2012

Harmful drinking and talking about alcohol in primary care: New Zealand population survey findings.

James A. Foulds; J. E. Wells; Cameron Lacey; Simon J. Adamson; Roger T. Mulder

Foulds J, Wells JE, Lacey C, Adamson S, Mulder R. Harmful drinking and talking about alcohol in primary care: New Zealand population survey findings.

Collaboration


Dive into the Cameron Lacey's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge